Dyne Therapeutics Q2 EPS $(1.08) Misses $(0.81) Estimate
Portfolio Pulse from Happy Mohamed
Dyne Therapeutics reported Q2 losses of $1.08 per share, missing the analyst consensus estimate of $0.81 by 33.33%. This represents a 6.93% increase in losses compared to the same period last year.
August 04, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dyne Therapeutics' Q2 losses per share were higher than expected, which could negatively impact the stock price in the short term.
Dyne Therapeutics reported higher than expected losses for Q2, missing the analyst consensus estimate by 33.33%. This negative earnings surprise could lead to a decrease in the stock price as it indicates the company's performance was worse than expected.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100